Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000596057 | SCV000706845 | uncertain significance | not provided | 2017-03-08 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001429604 | SCV001632321 | likely benign | Cholestanol storage disease | 2024-08-05 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004024796 | SCV003697673 | uncertain significance | Cardiovascular phenotype | 2022-11-17 | criteria provided, single submitter | clinical testing | The c.790G>A (p.V264M) alteration is located in exon 4 (coding exon 4) of the CYP27A1 gene. This alteration results from a G to A substitution at nucleotide position 790, causing the valine (V) at amino acid position 264 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Gene |
RCV000596057 | SCV005396168 | uncertain significance | not provided | 2024-05-08 | criteria provided, single submitter | clinical testing | In silico analysis indicates that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |